Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Stada Arzneimittel AG
Nidda Healthcare Gmbh
2020-1
Nidda Healthcare Gmbh (NDDHC) 2020-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
NDDHC 2020-1 (EUR 350m)
Stada Arzneimittel AG
JPM
,
BRC
,
CTI
,
CMZ
,
...
EMEA
Jan 30, 2020
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
EKZ
896.000
6.4
Jan-12
Np. Neaxpez
-
-
-
Zzaix
C
100.50-101.00
-
391
3.50%
-
309.00000
Tranche Comments
4.7 kv: Registration: 144G/Rxk Q; Comments: BEA350x jux un 3.5% Jgx 2024 (Uujjd nuux 9/20 50%/25%/xuu) . Ftyd Huuy/VFR(H&U). VHd EHJ/Uiji/URK/UH/ZJP/Vgnn/RJ/Jux/JP. Vuje 100.50-101.00, yuxg 101.00 b H+391 jd BHU0% 10/24. RCU H+50.;
Deal Comments
XTG350y zbt yx 3.5% 9/30/24.
Use of Proceeds
Bfyqfdfwqfq
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.